NCT07328243 2026-01-09
IRE-TCLN
First Affiliated Hospital of Zhejiang University
Phase NA Recruiting
Clinical Trials
36 trialsNCT06451445 2025-12-11
WIRED
University Health Network, Toronto
Phase NA Recruiting
NCT04276857 2025-05-13
SMART
University of Saskatchewan
Phase NA Recruiting
NCT05513443 2025-01-20
PRIS
Karolinska Institutet
Phase NA Recruiting
NCT02791503 2022-12-20
CROSSFIRE
Amsterdam UMC, location VUmc
Phase NA Completed
NCT05512663 2022-08-23
Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate Cancer
Jewish General Hospital
Phase NA Unknown
NCT03257150 2022-08-11
A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer
University Health Network, Toronto
Phase NA Completed
NCT04717687 2022-07-13
HOPE
Poitiers University Hospital
Phase NA Withdrawn
NCT02333773 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02335112 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02335827 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02425059 2021-09-05
Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430610 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430623 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430636 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430662 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430675 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430688 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430701 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430753 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430766 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430779 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT03337997 2021-05-06
A Pilot Study of IRE for Resectable Pancreatic Cancer
University of Saskatchewan
Phase NA Withdrawn
NCT04093141 2021-04-01
CHEMOFIRE-2
Aalborg University Hospital
Phase NA Unknown
NCT04404647 2021-03-26
Irreversible Electroporation of Unresectable Liver Tumors
Aalborg University Hospital
Phase NA Withdrawn
NCT02981719 2021-01-22
Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT03040453 2020-11-30
IRAL
Karolinska Institutet
Phase NA Withdrawn
NCT02828865 2020-07-07
A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers
National Taiwan University Hospital
Phase NA Completed
NCT02841436 2020-07-07
A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer
National Taiwan University Hospital
Phase NA Completed
NCT02430649 2020-05-27
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Withdrawn
NCT04310553 2020-03-17
An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally Advanced Pancreatic Cancer
RenJi Hospital
Phase NA Unknown
NCT02898649 2019-02-15
Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Yonsei University
Phase NA Unknown
NCT03169439 2017-05-30
Irreversible Electroporation for Treatment of Solid Abdominal Tumors
Assiut University
Phase NA Unknown
NCT01726894 2014-06-18
Nano
University College London Hospitals
Phase NA Unknown
NCT02010801 2013-12-13
Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors
National Taiwan University Hospital
Phase NA Completed
NCT01442324 2012-07-18
Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma
Azienda Ospedaliera di Padova
Phase NA Unknown